Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Pharmaengine Inc.

Headquarters: Taipei, Taiwan
Year Founded: 2003
Status: Public
Industry Sector: HealthTechnology
CEO: Hong Ren Wang, PhD
Number Of Employees: 44
Enterprise Value: $278,518,844
PE Ratio: 6.28
Exchange/Ticker 1: TPEx:4162
Exchange/Ticker 2: N/A
Latest Market Cap: $333,384,839

BioCentury | Jun 28, 2018
Distillery Techniques

Drug platforms

BioCentury | Jun 22, 2018
Clinical News

Nanobiotix’s NBTXR3 meets in Phase II/III for STS

BioCentury | Dec 22, 2017
Financial News

JHL delisting from TPEx

BioCentury | Dec 21, 2017
Financial News

JHL delisting from TPEx

BioCentury | Apr 4, 2017
Clinical News

NBTXR3: Ph II/III Act.In.Sarc ongoing

BioCentury | Jan 12, 2017
Company News

Merrimack, Ipsen deal

BioCentury | Jan 10, 2017
Company News

Ipsen acquiring Merrimack's marketed products

BioCentury | Nov 18, 2016
Company News

Onivyde sales and marketing update

BioCentury | Oct 24, 2016
Clinical News

Onivyde irinotecan regulatory update

BioCentury | Oct 18, 2016
Company News

Onivyde gains EU approval

Items per page:
1 - 10 of 74
Help Center
Username
Request a Demo
Request Training
Ask a Question